id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-2195-0003,FDA,FDA-2022-E-2195,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-22T04:00:00Z,2022,9,2022-09-22T04:00:00Z,,2022-09-22T15:24:53Z,,0,0,09000064853502a9
FDA-2022-E-2195-0001,FDA,FDA-2022-E-2195,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-09-12T04:00:00Z,2022,9,2022-09-12T04:00:00Z,,2022-09-12T14:45:48Z,,0,0,09000064852e9fa1
FDA-2022-E-2195-0002,FDA,FDA-2022-E-2195,Patent Extension Application from Morrison & Foerster LLP,Other,Application,2022-09-12T04:00:00Z,2022,9,2022-09-12T04:00:00Z,,2022-09-12T14:46:08Z,,0,0,09000064852e9fa3